Drug Database
Back to search

United States· US:52856-601_82f12b65-d2a0-450a-9f11-49ce8aad2e27

KEBILIDI

A eladocagene exuparvovec product containing eladocagene exuparvovec-tneq, registered in United States by PTC Therapeutics, Inc.. The same ATC class is registered in 10 of our 19 countries.

ATC A16AB26US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedKEBILIDIATCA16AB26REGISTER NO.US:52856-601_82f12b65…PACKS LISTED1CHECKEDJune 3, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eladocagene exuparvovec-tneqAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eladocagene exuparvovec is registered in 10 of 19 countries.

Countries holding a registration under ATC A16AB26 (eladocagene exuparvovec), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose
Search eladocagene exuparvovec products by name

Eladocagene exuparvovec · ATC A16AB26

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
eladocagene exuparvovec-tneq
Manufacturer
PTC Therapeutics, Inc.
Country
United States (US)
ATC code
A16AB26
ATC class
Eladocagene exuparvovec
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    5285660101
    1 VIAL, GLASS in 1 CARTON (52856-601-01) / .5 mL in 1 VIAL, GLASS (52856-601-11)

Regulatory notes

UNII (FDA substance ID)
S51J6N56M7
ELADOCAGENE EXUPARVOVEC
DailyMed SPL labels
1 version tracked

Same medicine, other countries

Eladocagene exuparvovec in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eladocagene exuparvovec products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Upstaza
  • Liechtenstein · Upstaza
  • Norway · Upstaza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4f6ec8d5-3107-400e-a9af-1ff1a3fc4a19
GET /v1/drugs/4f6ec8d5-3107-400e-a9af-1ff1a3fc4a19?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "S51J6N56M7",
    "rxcui": null,
    "inchikey": null,
    "display_name": "ELADOCAGENE EXUPARVOVEC",
    "substance_type": "structurallyDiverse",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRACEREBRAL",
  "spl_meta": {
    "9d6a6401-c6b5-4f29-af11-67707d249482": {
      "match": "brand_token",
      "title": "KEBILIDI (ELADOCAGENE EXUPARVOVEC-TNEQ) SUSPENSION [PTC THERAPEUTICS, INC.]",
      "spl_version": "3",
      "published_date": "2026-01-28"
    }
  },
  "productid": "52856-601_82f12b65-d2a0-450a-9f11-49ce8aad2e27",
  "productndc": "52856-601",
  "dosage_form": "SUSPENSION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ELADOCAGENE EXUPARVOVEC",
  "proprietary_name": "KEBILIDI",
  "active_ingred_unit": "{GC}/mL",
  "application_number": "BLA125722",
  "marketing_category": "BLA",
  "nonproprietary_name": "eladocagene exuparvovec-tneq",
  "start_marketing_date": "20241113",
  "active_numerator_strength": "560000000000"
}
API referenceMCP serverPlans

See everything about eladocagene exuparvovec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console